Completed
Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)
NCT02038946
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
- Winship Cancer Institute. Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States